AstraZeneca
The Director, DS&AI Products leads the end‑to‑end lifecycle of AI‑powered commercial and medical applications for oncology, shaping strategy, product roadmaps, and adoption across sales, marketing, and medical affairs. This role partners with brand and medical teams, oversees GenAI and agentic AI development, and ensures scalable, impact‑driven solutions that drive commercial lift and better patient outcomes.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
6% above the average for this role